Cost implications of implementation of pathogen‐inactivated platelets-Reference-Cited by-同舟云学术

Cost implications of implementation of pathogen‐inactivated platelets

Published:2015-05-18 Issue:10 Volume:55 Page:2312-2320
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

McCullough Jeffrey¹,Goldfinger Dennis²,Gorlin Jed³,Riley William J.⁴,Sandhu Harpreet⁵,Stowell Christopher⁶,Ward Dawn²,Clay Mary¹,Pulkrabek Shelley¹,Chrebtow Vera⁷,Stassinopoulos Adonis⁷

Affiliation:

1. Department of Laboratory Medicine and Pathology, University of MinnesotaMinneapolis Minnesota

2. Department of Laboratory Medicine and PathologyDavid Geffen School of Medicine at UCLALos Angeles California

3. Memorial Blood Centers/Innovative Blood ResourcesSt Paul Minnesota

4. College of the Science of Health Care DeliveryArizona State UniversityTempe Arizona

5. Stanford Blood CenterStanford University School of MedicineStanford California

6. Massachusetts General Hospital, Harvard Medical SchoolBoston Massachusetts

7. Global Scientific Affairs, Cerus CorporationConcord California

Funder

Cerus Corp

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.13149

Reference47 articles.

1. Component pathogen inactivation: a critical review

2. A patient-oriented risk-benefit analysis of pathogen-inactivated blood components: application to apheresis platelets in the United States

3. WhitakerBI HinkinsS. The 2011 national blood collection and utilization survey report. Department of Health and Human Services Washington (DC): 2012 [cited 2015 Apr 23]. Available from:http://www.hhs.gov/ash/bloodsafety/2011‐nbcus.pdf

4. Abstracts of the AABB Annual Meeting and CTTXPO. Denver, Colorado, USA. October 12‐15, 2013;Nikolis N;Transfusion,2013

5. Routine use of a rapid test to detect bacteria at the time of issue for nonleukoreduced, whole blood-derived platelets

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet Pathogen Reduction Technology—Should We Stay or Should We Go…?;Journal of Clinical Medicine;2024-09-10

2. Spoiled Rotten!;Immunohematology, Transfusion Medicine, Hemostasis, and Cellular Therapy;2023

3. Can transfusion-associated graft-versus-host disease (TA-GvHD) be prevented with leukoreduction alone?;Transfusion and Apheresis Science;2022-04

4. Severe Acute Respiratory Syndrome Coronavirus 2 and Blood Safety: An Updated Review;Transfusion Medicine and Hemotherapy;2022

5. Pathogen reduction technology for blood component: A promising solution for prevention of emerging infectious disease and bacterial contamination in blood transfusion services;Journal of Photochemistry and Photobiology;2021-12